GSK (GSK) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free GSK Stock Alerts $44.98 +0.10 (+0.22%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 12:23 PM | marketbeat.comGSK plc (NYSE:GSK) is Equity Investment Corp's 5th Largest PositionEquity Investment Corp reduced its position in GSK plc (NYSE:GSK - Free Report) by 1.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,243,259 shares of the pharmaceutical company's stock after sellinMay 17 at 7:56 AM | finance.yahoo.comGSK to divest remaining 4.2% stake in HaleonMay 17 at 7:56 AM | msn.comGSK completes sale of Haleon shares having raised £3.9bn since IPOMay 17 at 7:56 AM | bloomberg.comGSK to Sell Remaining $1.6 Billion Stake in HaleonMay 17 at 7:56 AM | thetimes.co.ukGSK sells remaining stake in Haleon for £1.2bnMay 17 at 7:56 AM | msn.comGSK raises $1.5 billion from sale of remaining Haleon stakeMay 17 at 2:56 AM | lse.co.ukLONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stakeMay 17 at 2:56 AM | marketwatch.comGSK Sells Last Haleon Shares for $1.58 BlnMay 17 at 2:56 AM | msn.comGSK raises £1.25bn as it offloads final stake in HaleonMay 17 at 2:56 AM | msn.comGSK raises $1.5 billion from offloading Haleon stake at a discountMay 17 at 2:22 AM | reuters.comGSK raises $1.5 bln from offloading Haleon stake at a discountMay 16 at 4:54 PM | ft.comGSK sells off remaining stake in HaleonMay 16 at 12:33 PM | reuters.comGSK intends to sell its remaining stake in HaleonMay 15 at 6:37 PM | msn.comGSK goes ex dividend tomorrowMay 15 at 12:28 PM | marketbeat.com216,942 Shares in GSK plc (NYSE:GSK) Bought by Moran Wealth Management LLCMoran Wealth Management LLC purchased a new stake in GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 216,942 shares of the pharmaceutical company's stock, valued aMay 13, 2024 | marketbeat.comQRG Capital Management Inc. Grows Stock Position in GSK plc (NYSE:GSK)QRG Capital Management Inc. boosted its stake in GSK plc (NYSE:GSK - Free Report) by 20.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 141,414 shares of the pharmaceutical company's stock after acquiringMay 11, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Sold by Lincluden Management Ltd.Lincluden Management Ltd. decreased its position in GSK plc (NYSE:GSK - Free Report) by 61.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 65,975 shares of the pharmaceutical company's stock aftMay 11, 2024 | finance.yahoo.comGSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four DaysMay 11, 2024 | americanbankingnews.comGSK Target of Unusually Large Options Trading (NYSE:GSK)May 10, 2024 | marketbeat.comInvestors Buy High Volume of GSK Call Options (NYSE:GSK)GSK plc (NYSE:GSK - Get Free Report) was the recipient of some unusual options trading on Friday. Stock traders purchased 16,167 call options on the company. This represents an increase of 238% compared to the average daily volume of 4,784 call options.May 8, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Purchased by Natixis Advisors L.P.Natixis Advisors L.P. boosted its position in shares of GSK plc (NYSE:GSK - Free Report) by 10.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 325,676 shares of the pharmaceutical company's stock after acquiMay 7, 2024 | msn.comGSK expands collaboration with BioVersys on tuberculosis asset alpibectirMay 7, 2024 | globenewswire.comBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionMay 6, 2024 | msn.comGenomics plc and GSK collaborate to harness polygenic risk scores in clinical trialsMay 4, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Sold by Raymond James Financial Services Advisors Inc.Raymond James Financial Services Advisors Inc. lowered its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 11.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 259,953 shares of the pharmaceuticalMay 3, 2024 | marketbeat.comFisher Asset Management LLC Raises Position in GSK plc (NYSE:GSK)Fisher Asset Management LLC boosted its position in GSK plc (NYSE:GSK - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 15,065,558 shares of the pharmaceutical company's stock after acqMay 2, 2024 | msn.comGSK, Boehringer Put Profits Over Safety, Zantac Jury ToldMay 2, 2024 | marketbeat.comGSK plc (NYSE:GSK) Declares Quarterly Dividend of $0.38GSK plc (NYSE:GSK) announced a quarterly dividend on Thursday, May 2nd. Shareholders of record on Friday, May 17th will be paid a dividend of 0.3762 per share by the pharmaceutical company on Thursday, July 11th. This represents a $1.50 annualized dividend and a yield of 3.47%. The ex-dividend date is Thursday, May 16th. This is an increase from GSK's previous quarterly dividend of $0.36.May 2, 2024 | reuters.comGSK knew about Zantac cancer risk, attorneys tell jury in first trialMay 2, 2024 | msn.comBiotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & MoreMay 2, 2024 | finance.yahoo.comGSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 2, 2024 | marketbeat.comGSK plc (NYSE:GSK) Stock Holdings Trimmed by Van ECK Associates CorpVan ECK Associates Corp lessened its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 9.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 529,588 shares of the pharmaceutical company's stock after selling 56,593 shares during the quarter. Van ECK AsMay 2, 2024 | gurufocus.comQ1 2024 GSK plc Earnings Call TranscriptMay 1, 2024 | marketwatch.comHealth Care Climbs as Pfizer, GSK Rise -- Health Care RoundupMay 1, 2024 | investorplace.com7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024May 1, 2024 | investorplace.comGSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | seekingalpha.comGSK Non-GAAP EPS of 43.10p, revenue of £7.4B; revised full-year profit forecast upwardsMay 1, 2024 | mirror.co.ukGSK raises profit growth forecasts for 2024 after 'strong start to year'May 1, 2024 | finance.yahoo.comGSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual OutlookMay 1, 2024 | marketbeat.comGSK (NYSE:GSK) Updates FY 2024 Earnings GuidanceGSK (NYSE:GSK) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.120-2.160 for the period, compared to the consensus estimate of 3.960. The company also issued revenue guidance of $41.2 billionillion-$41.2 billionillion, compared to the consensus estimate of $39.6 billionillion.May 1, 2024 | finance.yahoo.comGSK raises forecast, boosted by vaccinesMay 1, 2024 | barrons.comGSK Profit Drops In First Quarter On Higher CostsMay 1, 2024 | msn.comGSK raises annual profit outlook amid strong sales of shingles vaccinesMay 1, 2024 | msn.comGSK raises profit outlook on strong vaccine, HIV drug salesMay 1, 2024 | msn.comGSK Expects Higher Profits Boosted By Vaccines, Asthma DrugsMay 1, 2024 | msn.comGSK chief shrugs off concerns that FTSE bosses are not paid enoughMay 1, 2024 | uk.finance.yahoo.comGSK raises profit guidance as vaccine demand growsMay 1, 2024 | markets.businessinsider.comGSK Q1 Pretax Profit Declines; Updates 2024 GuidanceMay 1, 2024 | marketwatch.comAnalysts Saw GSK PLC 1Q Turnover at GBP7.07BMay 1, 2024 | marketwatch.comGSK Lifts Guidance After Turnover Beats Expectations -- Update Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land. Click here to see my #1 investment for 2024. GSK Media Mentions By Week GSK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.490.49▲Average Medical News Sentiment GSK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼1710▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bristol-Myers Squibb News Today Regeneron Pharmaceuticals News Today Vertex Pharmaceuticals News Today Zoetis News Today Sanofi News Today Takeda Pharmaceutical News Today Pfizer News Today Abbott Laboratories News Today Novartis News Today AstraZeneca News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
